NFKB1 and inflammatory bowel disease: Recent studies have shown that the Notch, Wnt, and NfkB signaling pathways are involved in the pathogenesis of IBD and different upstream signaling molecules can activate these pathways, thus serving as potential targets for the treatment of IBD.